Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBT vs IBBQ overlap: 25% of top holdings shared

Bottom line

How much do FBT and IBBQ overlap?

25% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 31.4% of FBT's assets and 29.6% of IBBQ's. They are substantially different portfolios, so owning both adds real diversification.

IBBQ holds far more positions (261 vs 32), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FBTIBBQ
Weight overlap (top 25)25%
Shared holdings10
Weight in shared holdings31.4%29.6%
Total positions32261
Expense ratio0.55%0.19%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings FBT and IBBQ have in common

Holding% of FBT% of IBBQOverlap
Illumina Inc ILMN3.92%1.98%1.98%
Neurocrine Biosciences Inc NBIX3.53%1.26%1.26%
Biogen Inc BIIB3.37%2.29%2.29%
Exelixis Inc EXEL3.32%1.04%1.04%
Incyte Corp INCY3.18%1.53%1.53%
Argenx Se ARGX3.13%1.89%1.89%
Vertex Pharmaceuticals Inc VRTX3.07%7.38%3.07%
Amgen Inc AMGN2.78%7.10%2.78%
United Therapeutics Corp UTHR2.56%1.94%1.94%
Alnylam Pharmaceuticals Inc ALNY2.52%3.19%2.52%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBT

  1. Corcept Therapeutics Inc — 5.60%
  2. Neogenomics Inc — 5.12%
  3. Veracyte Inc — 5.10%
  4. Bruker Corp — 4.32%
  5. Alkermes Plc — 4.24%
  6. Krystal Biotech Inc — 3.87%
  7. Natera Inc — 3.79%
  8. Axsome Therapeutics Inc — 3.71%
  9. Bio-techne Corp — 3.43%
  10. Arrowhead Pharmaceuticals Inc — 3.38%
  11. Halozyme Therapeutics Inc — 3.11%
  12. Repligen Corp — 3.07%
  13. Biomarin Pharmaceutical Inc — 2.83%
  14. Biontech Se — 2.63%
  15. Genmab A/s — 2.62%

Only in IBBQ

  1. Invesco Private Prime Fund — 14.20%
  2. Gilead Sciences, Inc. — 7.39%
  3. Invesco Private Government Fund — 5.48%
  4. Regeneron Pharmaceuticals, Inc. — 5.08%
  5. Revolution Medicines, Inc. — 2.48%
  6. Royalty Pharma PLC — 1.90%
  7. Insmed Inc. — 1.83%
  8. Roivant Sciences Ltd. — 1.71%
  9. Viatris Inc. — 1.49%
  10. Moderna, Inc. — 1.48%
  11. Guardant Health, Inc. — 1.35%
  12. Jazz Pharmaceuticals PLC — 1.16%
  13. Ascendis Pharma A/S — 1.10%
  14. Summit Therapeutics Inc. — 1.08%
  15. BridgeBio Pharma, Inc. — 1.02%

Asset mix

Asset typeFBTIBBQ
Stocks100.0%99.9%
Cash & short-term funds0.1%19.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryFBTIBBQ
US85.0%103.8%
IE4.2%1.9%
NL3.1%2.5%
GB—2.7%
DE2.6%0.9%
DK2.6%1.2%
CH2.5%1.2%
BM—1.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FBT and IBBQ overlap?
About 25% by weight. 10 securities appear in both funds' top 25 holdings; they make up 31.4% of FBT's assets and 29.6% of IBBQ's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do FBT and IBBQ have in common?
The largest shared holdings are Vertex Pharmaceuticals Inc, Amgen Inc, Alnylam Pharmaceuticals Inc, Biogen Inc, Illumina Inc.
Should I own both FBT and IBBQ?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, FBT or IBBQ?
IBBQ is broader, with 261 positions versus 32 for FBT. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.